Purchase Order N6809421P6057
Award Date 10/1/21
Potential Completion Date 4/30/22
Potential Value $231K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract, valued at $330,646.79, is for the delivery of controls, reagents, and consumables. This award is a call order under a Blanket Purchase Agreement (BPA) established by DHA, which has a $37 million ceiling and provides immunochemistry and clinical chemistry testing...
- Roche Diagnostics Corporation received a $200,000 delivery order from the Defense Health Agency for chemistry cost-per-reportable-result testing services, with a completion date of June 30, 2024. The award was issued on December 31, 2023, without a set-aside designation under open competition. This delivery order is a child contract stemming from Roche's established General Services Administration Schedule contract under the Critical Analyzers, Laboratory (FSS-66-III) schedule, which enables the...
- The Defense Health Agency awarded a delivery order valued at $482,006 to Roche Diagnostics Corporation for chemistry and immunoassay laboratory testing services on a cost-per-reportable-result basis. This non-set-aside contract, effective May 1, 2022, through April 1, 2023, will be performed at Roche's facility in Castleton, Indiana. The award utilizes firm fixed-price pricing under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration schedule, enabling the federal...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for in vitro diagnostic testing services. The contract, which is a Blanket Purchase Agreement (BPA) call valued at $741,441.86, was awarded by the Defense Health Agency (DHA) with a completion date of September 5, 2020. The contract has a firm fixed price pricing type and does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro...
- The Department of the Army Medical Command awarded a $177,482.40 firm fixed price delivery order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is for the provision of test reagents and has a completion date of September 30, 2022. Roche has previously received other federal contract awards, including Indefinite Delivery Contracts and Blanket Purchase Agreements, to supply a range of medical...
- This federal contract award was made by the Office of the Director, a civilian agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $22,825.44 Firm Fixed Price contract is a Blanket Purchase Agreement (BPA) call, with an ultimate completion date of December 31, 2013. The contract is not designated as a set-aside. Roche Diagnostics holds multiple significant...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical laboratory equipment. The $5,979,596 contract is for chemistry and immunoassay testing services to be performed at Fort Belvoir, Virginia, with a performance period ending on December 31, 2024. This contract is not designated as a set-aside. Roche Diagnostics holds several...
- The U.S. Defense Health Agency awarded a $1,691,672.05 firm-fixed-price definitive contract to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, for BRIDGE CHEMISTRY ANALYZER SERVICES and WAMC CHEMISTRY TESTING REAGENTS. The contract has an ultimate completion date of March 31, 2025. Roche Diagnostics is a global leader in diagnostic solutions and has multiple significant Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs)...
- This is a delivery order contract awarded to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $17,971.20 firm fixed-price award, placed by the Defense Health Agency, is for the provision of laboratory equipment and supplies without any set-aside designation. Roche Diagnostics has previously received prime and subcontract awards from various federal agencies, including the...
- This federal contract award is for a chemistry analyzer from Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The $9,280.72 firm fixed-price purchase order was awarded on October 1, 2021 by the Defense Health Agency, with an ultimate completion date of September 30, 2026. The contract does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostic products, laboratory instruments, and associated...